Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

CD40 employs p38 MAP kinase in IgE isotype switching

Author:
  • K. Brady
  • S. Fitzgerald
  • Sigurdur Ingvarsson
  • Carl Borrebaeck
  • P. N. Moynagh
Publishing year: 2001
Language: English
Pages: 276-281
Publication/Series: Biochemical and Biophysical Research Communications
Volume: 289
Issue: 1
Document type: Journal article
Publisher: Elsevier

Abstract english

IgE switching requires the prior induction of CE germline transcripts which is mediated by the concerted binding of STAT-6 and NF kappaB to the CE promoter. These transcription factors are regulated by IL-4 and CD40, respectively. However the latter can effect other signaling pathways and the present study explores the role of p38 MAPK in induction of CE germline transcripts. CD40 and IL-4, both alone and in synergy, were initially shown to activate the CE promoter in a B cell lymphoma cell line. Under the same conditions CD40 caused activation of p38 MAPK, whereas IL-4 was ineffective. The p38 MAPK inhibitor, SB203580, and a dominant negative form of p38 MAPK decreased the CD40 activation of the CE promoter by reducing the ability of CD40 to increase the transactivation potential of NF kappaB. This study suggests that p38 MAPK is crucially important in mediating CD40 activation of NFKB which acts to induce CE germline transcripts, ultimately facilitating IgE switching. (C) 2001 Academic Press.

Keywords

  • Biological Sciences
  • CD40
  • IgE
  • isotype switching
  • allergy
  • p38 MAP kinase
  • NF kappa B
  • ACTIVATED PROTEIN-KINASE
  • TUMOR-NECROSIS-FACTOR
  • CROSS-LINKING CD40
  • FACTOR-KAPPA-B
  • GERMLINE PROMOTER
  • CELLS
  • TRANSCRIPTION
  • INTERLEUKIN-4
  • EXPRESSION
  • MICE

Other

Published
  • ISSN: 1090-2104
Carl B
Carl Borrebaeck
E-mail: carl [dot] borrebaeck [at] immun [dot] lth [dot] se

Professor

Department of Immunotechnology

313k1

90

Director

Create Health

+46 46 222 96 13

313k1

90